An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gβ3 C825T polymorphism

Journal of Hypertension

Volumn 21, Issue 4, 2003, Pages 729-737

  Brand, Eva ^a   Wang, Ji Guang ^b   Herrmann, Stefan Martin ^a,c   Staessen, Jan A ^b,d  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Blood pressure; G protein; Gender; Genes; Haematocrit; Insulin resistance; Obesity

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; GENOMIC DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN;

ADULT; BELGIUM; BLOOD PRESSURE; CONFERENCE PAPER; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEMATOCRIT; HUMAN; HUMAN CELL; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE; SKINFOLD THICKNESS;

EID: 0038708277     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200304000-00016     Document Type: Conference Paper

References (44)

1. Farfel Z, Bourne HR, Iiri T. The expanding spectrum of G protein diseases. N Engl J Med 1999; 340:1012-1020.
2. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, et al. Association of a human G-protein β3 subunit variant with hypertension. Nat Genet 1998; 18:45-48.
3. i alpha 2 in mouse embryo stem cells promotes terminal differentiation to adipocytes. Am J Physiol 1993; 286:C1729-C1735.
4. Siffert W, Forster P, Jöckel KH, Mvere DA, Brinkmann B, Naber C, et al. Worldwlde ethnic distribution of the G protein β3 subunit 825T allele and its association with obesity in Caucasians, Chinese, and black African individuals. J Am Soc Nephrol 2001; 10:1921-1930.
5. 3 subunit gene (GNB3) 825T allele is associated with enhanced renal perfusion in early hypertension. Hypertension 2001; 37:882-886.
6. Siffert W. G protein β3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy. Nephrol Dial Transplant 2000; 16:1298-1306.
7. Schunkert H, Hense HW, Döring A, Riegger GAJ, Siffert W. Association between a polymorphism in the G protein β3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998; 32:510-513.
8. Brand E, Herrmann SM, Nicaud V, Ruidavets JB, Evans A, Arveiler D, et al. The 825C/T polymorphism of the G-protein subunit β3 is not related to hypertension. Hypertension 1999; 33:1175-1178.
9. Hengstenberg C, Schunkert H, Mayer B, Döring A, Löwel H, Hense HW, et al. Association between a polymorphism in the G protein β3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001; 49:820-827.
10. Cruickshank JK, Mbanya JC, Wilks R, Balkau B, McFarlane-Anderson N, Forrester T. Sick genes, sick individuals or sick populations with chronic disease? The emergence of diabetes and high blood pressure in African-origin populations. Int J Epidemiol 2001; 30:111-117.
11. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhäger WH, Herrmann SM, et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19:1349-1358.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
13. Levine MA, Smallwood PM, Moen PT Jr, Helman LJ, Ahn TG. Molecular cloning of beta 3 subunit, a third form of the G protein beta-subunit polypeptide. Proc Natl Acad Sci USA 1990; 87:2329-2333.
14. Hosmer DW Jr, Lemeshow S. Interpretation of coefficients. In: Applied logistic regression. New York: John Wiley & Sons; 1989, pp. 38-81.
15. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44:1049-1060.
16. Trégouët DA, Ducimetière P, Tiret L. Testing associations between candidate-gene markers and phenotype in related individuals by use of estimating equations. Am J Hum Genet 1997; 81:189-199.
17. Raine AEG. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure. Implications of erythropoietin therapy. Lancet 1988; i:97-100.
18. Vaziri ND. Cardiovascular effects of erythropoietin and anemia correction. Curr Opin Nephrol Hypertens 2001; 10:633-637.
19. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-protein β3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 1998; 32:1094-1097.
20. Beige J, Hohenbleicher H, Distler A, Sharma AM. G-protein β3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension 1999; 33:1049-1051.
21. Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP. Association between the C825T polymorphism of the G protein β3-subunit gene and hypertension in blacks. Hypertension 1999; 34:1193-1196.
22. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y. G protein β3 subunit variant and essential hypertension in Japanese. Hypertension 1998; 32:935-938.
23. Ishikawa K, Imai Y, Katsuya T, Ohkubo T, Tsuji I, Nagai K, et al. Human G-protein β3 subunit variant is associated with serum potassium and total cholesterol levels but not with blood pressure. Am J Hypertens 2000; 13:140-145.
24. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000; 36:1297-1300.
25. Hegele RA, Harris SB, Hanley AJG, Cao H, Zinman B. G Protein β3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension 1998; 32:688-692.
26. 3 subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension 2000; 35(part 2):214-218.
27. 3 subunit gene (GNB3) is associated with impaired left ventricular diastolic filling in essential hypertension. J Hypertens 1999; 17:1457-1462.
28. Hegele RA, Anderson C, Young TK, Connelly PW. G-protein β3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res 1999; 9:972-977.
29. Gutersohn A, Naber C, Müller N, Erbel R, Siffert W. G protein β3 subunit 825TT genotype and post-pregnancy weight retention. Lancet 2000; 355:1240-1241.
30. Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima M, Ando T, et al. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 2000; 96:941-949.
31. Haslauer M, Baltensperger K, Porzig H. Erythropoietin- and stem cell factor-induced DNA synthesis in normal human erythroid progenitor cells requires activation of protein kinase Cα and is strongly inhibited by thrombin. Blood 1999; 94:114-126.
32. i proteins to the erythropoietin receptor. J Biol Chem 2001; 278:2007-2014.
33. 2 mediates erythropoietin signal transduction in human erythroid precursors. J Clin Invest 1996; 98:1728-1736.
34. Kesselring F, Spicher K, Porzig H. Changes in G protein pattern and in G protein-dependent signaling during erythopoietin- and dimethylsulfoxide-induced differentiation of murine erythroleukemia cells. Blood 1994; 84:4088-4098.
35. Clejan S, Mallia C, Vinson D, Dotson R, Beckman BS. Erythropoietin stimulates G-protein-coupled phospholipase D in haematopoietic target cells. Biochem J 1996; 314:853-860.
36. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T polymorphism of the G protein β3-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001; 37(part 2):739-743.
37. Strazzullo P, Barba G, Cappuccio P, Siani A, Trevisan M, Farinaro E, et al. Altered renal sodium handling in men with abdominal adiposity: a link to hypertension. J Hypertens 2001; 19:2157-2164.
38. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97:1766-1772.
39. Higaki J, Baba S, Katsuya T, Sato N, Ishikawa K, Mannami T, et al. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men. The Suita Study. Circulation 2000; 101:2060-2065.
40. Wang JG, Staessen JA, Barlassina C, Fagard R, Kuznetsova T, Struijker Boudier HA, et al. Association between hypertension and variation in the α- and β-adducin genes in a white population. Kidney Int 2002; 62:2152-2159.
41. Jamerson KA, Schork N, Julius S. Effect of home pressure and gender on estimates of the familial aggregation of blood pressure. The Tecumseh Blood Pressure Study. Hypertension 1992; 20:314-318.
42. Le Mellay V, Lasmoles F, Lieberherr M. Galpha(q/11) and gbetagamma proteins and membrane signalling of calcitriol and estradiol. J Cell Biochem 1999; 75:138-146.
43. Oparil S. Hormones and vasoprotection. Hypertension 1999; 33(part 2):170-176.
44. Goodman SN. Towards evidence-based medical statistics. 1: the P value fallacy. Ann Intern Med 2000; 130:995-1004.